MetLife had its Relative Strength (RS) Rating upgraded from 69 to 74 Wednesday — a welcome improvement, but still below the 80 or higher score you look for.
IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains tend to have an 80 or higher RS Rating as they launch their largest runs. See if MetLife can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
MetLife is trying to complete a cup with handle with an 88.09 buy point. See if it can clear the breakout price in heavy trade.
While revenue growth fell last quarter from 16% to -2%, EPS grew 8%, up from -1% in the prior report.
The company earns the No. 6 rank among its peers in the Insurance-Life industry group. Lincoln National, Corebridge Financial and Primerica are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
